Vials labelled ‘Astra Zeneca Covid-19 Coronavirus Vaccine’ and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.

KUALA LUMPUR, Mar 15 — Malaysia will proceed with the purchase and acquisition of AstraZeneca Covid-19 vaccines as there has been no evidence that the vaccine causes blood clots, said National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin.